[Federal Register Volume 64, Number 23 (Thursday, February 4, 1999)]
[Notices]
[Pages 5678-5679]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-2679]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated July 13, 1998, and published in the Federal 
Register on July 29, 1998, (63 FR 40543), Novartis Pharmaceuticals 
Corp., Regulatory Compliance, 556 Morris Avenue, Summit, New Jersey 
07901, made application by renewal to the Drug Enforcement 
Administration (DEA) to be registered as a bulk manufacturer of 
methylphenidate (1724), a basic class of controlled substance listed in 
Schedule II.
    The firm plans to manufacture finished product for distribution to 
its customers.

[[Page 5679]]

    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, Section 823(a) and 
determined that the registration of Novartis Pharmaceuticals Corp. to 
manufacture methylphenidate is consistent with the public interest at 
this time. DEA has investigated Novartis Pharmaceuticals Corp. on a 
regular basis to ensure that the company's continued registration is 
consistent with the public interest. These investigations have included 
inspection and testing of the company's physical security systems, 
audits of the company's records, verification of the company's 
compliance with state and local laws, and a review of the company's 
background and history. Therefore, pursuant to 21 U.S.C. Sec. 823 and 
28 CFR Secs. 0.100 and 0.104, the Deputy Assistant Administrator, 
Office of Diversion Control, hereby orders that the application 
submitted by the above firm for registration as a bulk manufacturer of 
the basic class of controlled substance listed above is granted.

    Dated: January 22, 1999.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 99-2679 Filed 2-3-99; 8:45 am]
BILLING CODE 4410-09-M